LSI is Officially Heading to Singapore — Register for LSI Asia '25 Today
Learn More About TESARO
TESARO
image
Compounds for oncology indications, including: 1-the prevention of A) chemotherapy-induced nausea and vomiting (CINV), B) post-operative nausea and vomiting (PONV), and C) chronic cough and 2-treatment for patients with non-small cell lung cancer (NSCLC) whose tumors express an Anaplastic Lymphoma Kinase (ALK) fusion protein
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next